Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Recommended lepirudin dose for HIT is too high

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Tardy B, Lecompte T, Boelhen F, Tardy-Poncet B, Elalamy I, Morange P, Gruel Y, Wolf M, François D, Racadot E, Camarasa P, Blouch MT, Nguyen F, DOUBINE S, Dutrillaux F, Alhenc-Gelas M, Martin-Toutain I, Bauters A, Ffrench P, de Maistre E, Grunebaum L, Mouton C, Huisse MG, Gouault-Heilmann M, Lucke V, GEHT-HIT Study Group.Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin. Blood 108: 1492-1496, No. 5, 1 Sep 2006

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Recommended lepirudin dose for HIT is too high. React. Wkly. 1121, 4 (2006). https://doi.org/10.2165/00128415-200611210-00010

    Download citation

    Keywords

    • Thrombocytopenia
    • Predictive Factor
    • Major Haemorrhage
    • Evaluable Patient
    • Dose Recommendation